Introduction
Appearance of uracil in DNA, either as a result of cytosine deamination or erroneous nucleotide incorporation of DNA polymerases, usually a mistake that needs to be excised [1] . To avoid mutations, several DNA damage recondition and repair pathways have been developed during evolution. The base excision repair pathway (BER) corrects DNA base damages arising e.g. from oxidation, deamination or alkylation. The damage is generally the result of the spontaneous decay of DNA that occurs during physiological processes. However, similar base mismatch may be caused by radiation and environmental chemicals as well [2, 3] .
As the initial step in BER, the damaged or mismatched base is recognized by a DNA glycosylase. The removal of the modified base performed by these enzymes does not cause major distortions to the DNA duplex. Uracil-DNA glycosylase (UDG) employs a nucleotide-flipping mechanism in which the target uracil is extruded out of the DNA double helix and recognized by the active site of the enzyme, where catalysis takes place. Simultaneously, a bulky hydrophobic or aromatic residue is usually inserted into the DNA helix to take the position of the displaced base [4] .The enzyme hydrolyses the N-C1' glycosidic bond linking the uracil base to the deoxyribose sugar moiety. Glycosylase action leaves an abasic site that is further processed by short-patch repair or long-patch repair mechanisms that use largely different enzymes [5, 6] . The abasic site that is removed by a 5'-acting apurinic/apyrimidinic (AP) endonuclease and a deoxyribophosphodiesterase (dRpase), leaving a gap that is filled by DNA polymerase and closed by DNA ligase [7] .
Three structurally unrelated inhibitors of uracil-DNA glycosylase have been identified to date. These include the Uracil Glycosylase Inhibitor (UGI) of Bacillus subtilis bacteriophage PBS1, the p56 protein encoded by the B. subtilis phage ϕ29 and the Staphylococcus specific uracil-glycosylase inhibitor (SAUGI) [7] [8] [9] [10] . The three dimensional structures have also been determined for all the three inhibitor proteins in complex with their respective binding partners. In all 3D structures, the negatively charged residues of the inhibitors follow a recognition pattern that closely mimics the UDG-bound DNA [8] [9] [10] .
In the UDG inhibitor research, the UGI protein was the first to be described and a straightforward physiological function could also be defined in this case. Namely, the genome of B. subtilis bacteriophages PBS1 and PBS2 naturally contain uracil in place of thymines, thus it produces UGI proteins to protect their genomic DNA from host UDG repair enzymes [8] [9] [10] . The second reported inhibitor, termed as p56, is a small, 56-residue-long acidic polypeptide encoded by the B. subtilis lytic phage ϕ29. Unlike PBS2 phage, the DNA genome of ϕ29 does not contain uracil residues. Protein p56 is synthesized upon ϕ 29 infection and knocks out a host-encoded BER system that could be harmful for viral replication if uracil residues arise in the replicative intermediates [9, [13] [14] [15] . Last, the S. aureus uracil-DNA glycosylase (SAUGI) have been identified in 2014 [10] . While within this study the structure of SAUGI: SAUDG complex has been solved, the biological role of SAUGI still remains unclear, with several hypotheses being proposed. SAUGI may facilitate increased incorporation of uracil into the viral genome, and this replacement may efficiently block the replication of various DNA viruses [10] . According to another theory, the SAUGI protein has an inherently increased affinity towards viral UDGs and this may also be further tailored, e.g. inhibition of herpes viral UDG can be largely elevated [16] .
In the present work, we focused on one of the naturally occurring residue variation of the SAUGI proteins encoded by different Staphylococcal strains. Namely we investigated the SAUGI E24H variant as compared to the SAUGI described in [10] which is termed here as wild type (SAUGI WT ). We employed two independent biophysical methods and also provided a structural modelling for comparisons. Our data suggest that the exchange of glutamate to histidine at this specific location does not result in heavy perturbation of the interaction.
Materials and Methods

In silico Blast search and alignments
Blast search for homologous sequences of SAUGI proteins, was performed using NBCI Blast and the wild type SAUGI sequence (UniProt accession code: Q936H5). The search was performed using translated nucleotide query (blastx), in the non-redundant protein sequences database, in S. aureus (taxid: 1280) organism. The alignment was done on sequences with the similarity higher than 90%, then adjusted manually. At the 24 th residue of SAUGI, 70% of the aligned sequences contained glutamate whereas the remaining 30% histidine.
Cloning and mutagenesis
pET21b vectors encoding SAUDG and SAUGI (later termed as SAUGI WT ) were kind gifts from Hao-Ching Wang, from Taipei Medical University [10] . We have re-cloned the DNA coding sequence of SAUGI into the pET15b vector that also includes an N-terminal His 6 epitope tag. The SAUGI mutant construct (SAUGI E24H ) was engineered by site-directed mutagenesis from SAUGI WT [17] using the QuikChange method (Agilent). Primers used for mutagenesis (Table 1) were synthesized by Eurofins MWG GmbH. Constructs were verified by DNA sequencing at Eurofins MWG GmbH. 
SAUGI and SAUDG protein expression and purification
Plasmids for the production of SAUDG, SAUGI WT and SAUGI E24H were transformed into E. coli Rosetta BL21 (DE3) PlysS cells (Novagen). The cells were grown in LB medium at 37°C, and induced at OD 600nm = 0.6 with 0.6 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG), followed by overnight expression at 16 °C, then, harvested by centrifugation (4 °C, 4000 g, 20 min). The pellet was lyzed in lysis buffer containing 50 mM Tris HCl, pH 8.0, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 5 mM β-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride, 5 mM benzamidine, 0.1 mg/ml lysozyme, 0.1 mg/ ml DNase (Sigma, St. Louis, MO, USA) and 0.01 mg/ml RNase A (Invitrogen, Carlsbad, CA, USA). Cell extraction was achieved by Potter-Elvehjem homogenization and further assisted by sonication. Cell debris were pelleted by centrifugation at 20 000 × g for 30 min. Supernatant was applied onto a Ni-NTA column (Qiagen, Hilden, Germany) and washed with a set of washing buffers: low salt buffer (50mM HEPES, pH 7.5, 30 mM KCl, 5 mM β-mercaptoethanol), high salt buffer (50 mM HEPES, pH 7.5, 300 mM KCl, 5 mM β-mercaptoethanol) and wash buffer (50mM HEPES, pH 7.5, 30 mM KCl, 50 mM imidazole, 5 mM β-mercaptoethanol). Constructs were finally eluted with elution buffer (50 mM HEPES, pH 7.5, 30 mM KCl, 500 mM imidazole, 5 mM β-mercaptoethanol) and dialyzed against the following phosphate buffer: 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , pH 7.5. Purity of SAUDG (Mw: 26032 Da), SAUGI WT (Mw: 15520 Da) and SAUGI E24H (Mw: 15528 Da) constructs was assessed by SDS-PAGE (not shown).
Microscale thermophoresis (MST)
The interaction of SAUDG and SAUGI proteins was studied using microscale thermophoresis (MST) as implemented in the NanoTemper Monolith NT.115 instrument (Nanotemper Technologies GmbH, Germany). We used Premium Nanotemper capillaries with 60% light emitting diode power and 95% MST power for 40 s at 20 °C. SAUDG was labelled using the Monolith NT.115 NT-647 RED-NHS amine reactive protein labelling kit according to the NanoTemper protocol. Unlabelled SAUGI WT or SAUGI E24H was diluted in sixteen twofold dilution n series starting from 2.5 mM. 5 nM of the labelled SAUDG was added to each dilution of SAUGI variants and the complex was incubated for 10 minutes at room temperature in the final buffer containing 50 mM Tris HCl pH 7.4, 150 mM NaCl, 10 mM MgCl 2 , 0.05% Tween 20. Data were analysed using the software provided by the manufacturer. Quadratic fit to the data according to mass law of action was used for apparent K D calculation. Each experiment was done in triplicate.
Isothermal titration calorimetry (ITC)
Calorimetric measurements were performed on a MicroCal-ITC 200 titration calorimeter (Malvern) at 20°C. The protein samples were co-dialysed overnight against phosphate buffered saline (PBS) pH 7.5 including 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 and also supplemented with 0.5 mM Tris(2-carboxyethyl)phosphine (TCEP). In the experimental setup, the cell of the instrument was filled with 20 μM SAUGI WT or SAUGI E24H and the syringe with 200 μM SAUDG. Each titration included 19 steps of injection with 2 μl of ligand per injection spaced 180 s apart from each other, with the injection syringe rotating at 750 r.p.m. The titration data were analysed using MICROCAL ORIGIN software, following the directions of the manufacturer, in order to calculate the thermodynamic parameters: dissociation constant (K D ), stoichiometry (N), enthalpy (ΔH) and entropy (ΔS).
Results and Discussion
The complex formation of SAUDG with SAUGI WT and SAUGI E24H variants were first assessed by MST (Fig. 1) . The thermophoresis induced fluorescence change of NT-647 dye labelled SAUDG clearly indicated the binding interaction of SAUDG with both SAUGI variants. While the binding curves had similar appearance for both SAUGIs, the obtained apparent K D values of 0.01 ± 0.05 nM indicated that the qualitative determination of the dissociation constants for these interactions cannot be accomplished under the experimental conditions due to the relative high affinity of SaUGI-SAUDG interaction. Therefore, we investigated these interactions by ITC to account for the qualitative characterization of binding affinity and energetics.
ITC is a highly relevant biophysical technique for biomolecular interaction analysis which in addition to binding affinity also simultaneously reports stoichiometry and the enthalpic component of complex formation. Titration of SAUDG to both SAUGI variants provided similar binding affinities and a one to one stoichiometry of interaction (Fig. 2) . Importantly, Fig. 2 and Fig. 3 show a drastic change in the thermodynamic character of the interaction for the wild type and the mutant cases. In the complexation of SAUDG and SAUGI WT favourable enthalpic and entropic components could be detected, while in the case of SAUGI E24H , binding is governed by large favourable entropic component opposed by small unfavourable binding enthalpy. We consider that our ITC experiments are reliable in terms of binding energetics characterization even despite the presence of the background noise. Yet the obtained KD values are far from the ones published before for SAUDG: SAUGI WT interaction [10] . Additional experiments, e.g. parallel measurements reverse ITC titration or a displacement titration, are required to better describe the binding affinity of the SAUDG: SAUGI interaction.
To further explore the effect of the mutation we also modelled this residue change into the experimentally determined 3D structure of the SAUDG: SAUGI complex [10] , using the built-in Mutagenesis module of the PyMOL program (PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC). The most probable histidine conformer of the E24H mutation is visualized on Fig. 4 .
In the wild type complex the Glu 24 residue participates in solvent mediated polar contacts with SAUDG Lys 79 , Gln 66 and Pro 64 which may be affected by the replacement of this glutamate to histidine. Note that water-mediated polar interactions often play an instrumental role in stabilization of protein-protein interactions e.g. in case of [19, 20] . However, potential alterations of indirect interprotomer interactions due to the different variants cannot be faithfully interpreted on the sole basis of the in silico model. To account for the in-depth molecular basis of the E24H mutation, additional evidences from, e.g. molecular dynamics or high resolution x-ray crystal structures may be required.
Conclusions
The biochemical properties of glutamate and histidine residues show clear differences with regard to electrostatic charge, aromaticity and involvement in hydrogen bond interactions as acceptor or donor. However, in our specific situation the performed biophysical measurements suggest that the affinity of the interaction between the SAUDG glycosylase and its SAUGI inhibitor was not largely altered by the replacement of SAUGI Glu24 to His at the interprotomer interaction surface. Despite the observed differences in binding energetics, our in vitro characterization suggests that both SAUGI WT and SAUGI
E24H
variants have similar physiological role in SAUDG inhibition. This finding potentially underlines the significance of this interaction for the pathogenic Staphylococcus organism. 
